opioid Archives

New model helps expand opioid use care options

Feb. 3, 2022—Vanderbilt is using an innovative hub and spoke treatment model to care for patients with opioid use disorder.

Opioid use disorder treatment access increases in areas with large Medicaid population

Jan. 4, 2022— by Jill Clendening Researchers report that in communities where Medicaid is a more common source of insurance, providers of buprenorphine, an effective treatment for opioid use disorder (OUD), are much less likely to discriminate between Medicaid and privately insured prospective patients, but patients with either type of coverage still face many barriers to obtaining...

Artificial intelligence predicts opioid overdose in Tennessee

Oct. 19, 2021—Researchers at Vanderbilt and the Tennessee Department of Health have developed 30-day predictive models for fatal and non-fatal opioid-related overdose among patients receiving opioid prescriptions in the state.

Study finds increased risk of serious opioid events in mothers, regardless of dose

Apr. 26, 2021—A new study from Vanderbilt University Medical Center researchers finds that new mothers who receive opioids after uncomplicated vaginal births face an increased risk of serious opioid-related events regardless of the opioid dosage, a finding that could significantly impact care delivery.

Codeine metabolizer status in clinical practice

Apr. 5, 2021—Vanderbilt researchers have developed a response score using genetic and clinical information to aid prescribing of the widely used pain medication codeine.

Program using telehealth to treat Opioid Use Disorder

Feb. 11, 2021—The Vanderbilt Maternal Addiction Recovery Program (VMARP) is offering virtual appointments to help reach patients in Nashville’s outlying areas for treatment of Opioid Use Disorder (OUD).

Study shows drastic increases in opioid-affected births

Jan. 12, 2021—The rate of mothers who had an opioid-related diagnosis when delivering their baby increased by 131% from 2010-2017, as the incidence of babies diagnosed with drug withdrawal, known as neonatal abstinence syndrome (NAS), increased by 82% nationally during that same time period.

VA adopts enhanced recovery for total knee, total hip patients

Jan. 7, 2021—For patients receiving total knee or total hip replacements at the Nashville VA Medical Center, the use of opioids for inpatient pain management and the total time patients spent in the hospital were both greatly reduced following the January 2016 adoption of sweeping quality improvement measures.

Model helps predict which infants may go on to develop NAS

Nov. 12, 2020—A new Vanderbilt-designed prediction model may make it easier to determine which infants will go on to develop neonatal abstinence syndrome (NAS), a drug withdrawal syndrome in newborns that occurs after exposure to opioids during pregnancy.